Israeli AI precision oncology co Nucleai raises $33m
Israeli AI precision cancer drug treatment company Nucleai today announced that it has completed a $33 million Series B financing round, co-led by Section 32 and Sanofi…
Recover your password.
A password will be e-mailed to you.